Glenmark Life Science Shareholding Pattern

ALIVUS|543322|Pharmaceuticals
1,107.00+₹4.20 (0.38%)

As on 24 Jul, 2026 | 15:29 IST

Shareholding Pattern

Promoters (74.87%)

Mutual Funds (5.65%)

Retail and other (12.41%)

Foreign institutions-FII (5.54%)

Other domestic institutions (1.53%)

Promoters

Summary Data

Category
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Promoters
74.87%
74.87%
74.91%
74.91%
Foreign institutions-FII
5.54%
5.29%
5.09%
6.84%
Other domestic institutions
1.53%
1.64%
1.68%
1.60%
Retail and other
12.41%
12.56%
12.88%
12.78%
Mutual Funds
5.65%
5.63%
5.44%
3.87%

FAQs

What is the promoter shareholding of Glenmark Life Science?

Plus

The promoters of Glenmark Life Science currently hold 74.87% of the company’s total shares.

What is the FII and DII shareholding of Glenmark Life Science?

Plus

Foreign Institutional Investors (FIIs) own 5.54%. Domestic Institutional Investors (DIIs) hold 1.53% of Glenmark Life Science.

What is the retail shareholding of Glenmark Life Science?

Plus

The retail shareholding of Glenmark Life Science is 12.41%

How often is the shareholding pattern of Glenmark Life Science updated?

Plus

The shareholding pattern of Glenmark Life Science is updated quarterly as per SEBI regulations.